GLP1R and Parkinson disease: In addition, a previous study demonstrated that NLY01, a GLP1R agonist, protects dopaminergic neurons from death and improves behavioral recovery in Parkinson’s disease, which is mediated by the block of A1 astrocyte transformation [10].